| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CONTRAFECT Corp | Director | Options (Right to Buy) | 42K | $141K | $3.35 | 17 May 2022 | Direct |
| SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 22.7K | $50.4K | $2.22 | 05 Jun 2025 | Direct |
| Viracta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | 20 Jun 2024 | Direct | ||
| SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 25K | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SERA | SERA PROGNOSTICS, INC. | 05 Jun 2025 | 2 | $0 | 4 | Director | 06 Jun 2025, 18:37 |
| VIRX | Viracta Therapeutics, Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 24 Jun 2024, 19:43 |
| SERA | SERA PROGNOSTICS, INC. | 06 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 16:31 |
| SERA | SERA PROGNOSTICS, INC. | 08 Jun 2023 | 1 | $0 | 4 | Director | 07 Jul 2023, 16:23 |
| VIRX | Viracta Therapeutics, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 18:11 |
| VIRX | Viracta Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:51 |
| CFRX | CONTRAFECT Corp | 17 May 2022 | 1 | $141K | 4 | Director | 18 May 2022, 20:12 |
| SERA | SERA PROGNOSTICS, INC. | 11 Apr 2022 | 1 | $0 | 4 | Director | 12 Apr 2022, 17:22 |
| SERA | SERA PROGNOSTICS, INC. | 11 Apr 2022 | 0 | $0 | 3 | Director | 12 Apr 2022, 17:20 |
| VIRX | Viracta Therapeutics, Inc. | 16 Aug 2021 | 1 | $0 | 4 | Director | 17 Aug 2021, 18:10 |
| VIRX | Viracta Therapeutics, Inc. | 14 Aug 2021 | 0 | $0 | 3 | Director | 17 Aug 2021, 18:03 |